What is the recommended dose of ketamine (Ketamine) for agitation?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 17, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Recommended Ketamine Dosing for Agitation

For acute agitation, the recommended ketamine dose is 2 mg/kg IM or 1-1.5 mg/kg IV, with continuous monitoring of vital signs and airway status. 1, 2

Dosing by Route of Administration

Intravenous (IV) Administration

  • Initial dose: 1-1.5 mg/kg IV for rapid sedation of agitated patients 1
  • Onset of action: 30-96 seconds, allowing for quick intervention 1
  • Recovery time: Average 84 minutes (range 22-215 minutes) 3
  • Higher doses (>2.5 mg/kg IV) are associated with increased risk of adverse effects including emesis 4

Intramuscular (IM) Administration

  • Initial dose: 2-4 mg/kg IM for severe agitation 1, 2
  • Traditional higher doses (4-6 mg/kg IM) may carry increased risk of intubation 5
  • Reduced-dose protocol (2 mg/kg IM) has shown 87% effectiveness with lower intubation rates 2
  • Onset of action: Approximately 3-5 minutes 1
  • Recovery time: Slightly longer than IV administration, approximately 90 minutes 3

Monitoring Requirements

  • Continuous monitoring of vital signs is essential during both administration and recovery 1
  • Key parameters to monitor:
    • Oxygen saturation (should remain >93% on room air) 1
    • Heart rate (expect increase of approximately 8-18%) 1, 6
    • Blood pressure (expect increase of approximately 17 mm Hg systolic) 6

Potential Adverse Effects

  • Respiratory:

    • Transient hypoxia: 1.8% of cases 5
    • Laryngospasm: 1.3% of cases 5
    • Higher intubation rates when used by ground EMS (30.5%) compared to ED administration (1.8%) 5
  • Gastrointestinal:

    • Emesis: 5.2-8.4% of cases, with higher risk in early adolescents and with IM administration 4, 5
  • Neurological:

    • Mild recovery agitation: 7.6% of cases 4
    • Clinically significant agitation: 1.4-3.5% of cases 4, 5

Important Clinical Considerations

  • 62.5% of patients may require additional medication for continued agitation after initial ketamine dose 6
  • Ketamine is often effective as a second-line agent when other sedatives have failed 2
  • Risk factors for increased adverse events:
    • Unusually high IV doses (initial >2.5 mg/kg or total >5.0 mg/kg) 4
    • Low IM doses (<3.0 mg/kg) may be associated with inadequate sedation 4
    • Increasing age (peak emesis risk at 12 years) 4

Special Populations

  • Alcohol or drug intoxication:

    • Present in 40.6% of patients receiving ketamine for agitation in one study 6
    • No significant increase in adverse effects even with 21.9% alcohol intoxication 6
    • Use caution and consider dose reduction in intoxicated patients 1
  • Contraindications:

    • Use should be avoided in patients with ischemic heart disease, cerebrovascular disease, or uncontrolled hypertension 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.